| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Nadia Solowij, Patricia T Michi. Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia? Journal of psychiatry & neuroscience : JPN. vol 32. issue 1. 2007-02-26. PMID:17245472. |
cognitive dysfunction associated with long-term or heavy cannabis use is similar in many respects to the cognitive endophenotypes that have been proposed as vulnerability markers of schizophrenia. |
2007-02-26 |
2023-08-12 |
Not clear |
| Alan I Green, E Sherwood Brow. Comorbid schizophrenia and substance abuse. The Journal of clinical psychiatry. vol 67. issue 9. 2007-02-23. PMID:17081075. |
the primary substances of abuse among schizophrenia patients are alcohol, cannabis, cocaine, and nicotine. |
2007-02-23 |
2023-08-12 |
Not clear |
| Kelly A Newell, Chao Deng, Xu-Feng Huan. Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia. Experimental brain research. vol 172. issue 4. 2007-01-26. PMID:16710682. |
a significant 25% increase in cb1 binding was found in the superficial layers (layer i, ii) of the pcc of schizophrenia subjects compared to controls, none of whom had recently used cannabis. |
2007-01-26 |
2023-08-12 |
human |
| J Boydell, J van Os, A Caspi, N Kennedy, E Giouroukou, P Fearon, M Farrell, R M Murra. Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999. Psychological medicine. vol 36. issue 10. 2007-01-24. PMID:16854250. |
there is evidence that cannabis use might be relevant to the aetiology of schizophrenia. |
2007-01-24 |
2023-08-12 |
Not clear |
| J Boydell, J van Os, A Caspi, N Kennedy, E Giouroukou, P Fearon, M Farrell, R M Murra. Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999. Psychological medicine. vol 36. issue 10. 2007-01-24. PMID:16854250. |
we aimed to measure any change in cannabis use over time in those first presenting with schizophrenia in south-east london from 1965 to 1999, and compare this with change in use in those presenting with non-psychotic psychiatric disorders. |
2007-01-24 |
2023-08-12 |
Not clear |
| V G Kenchadze, E D Chkonii. [Clinical features of cannabis psychosis in schizophrenia patients]. Georgian medical news. issue 137. 2007-01-22. PMID:16980745. |
[clinical features of cannabis psychosis in schizophrenia patients]. |
2007-01-22 |
2023-08-12 |
Not clear |
| V G Kenchadze, E D Chkonii. [Clinical features of cannabis psychosis in schizophrenia patients]. Georgian medical news. issue 137. 2007-01-22. PMID:16980745. |
for thorough investigation psychopathology due to marijuana intoxication, we examine two groups of schizophrenia patients. |
2007-01-22 |
2023-08-12 |
Not clear |
| V G Kenchadze, E D Chkonii. [Clinical features of cannabis psychosis in schizophrenia patients]. Georgian medical news. issue 137. 2007-01-22. PMID:16980745. |
i group--14 patients, who had long history of cannabis use before developing schizophrenia, and ii group--schizophrenic patients, who already had schizophrenia and later became marijuana users. |
2007-01-22 |
2023-08-12 |
Not clear |
| V G Kenchadze, E D Chkonii. [Clinical features of cannabis psychosis in schizophrenia patients]. Georgian medical news. issue 137. 2007-01-22. PMID:16980745. |
peculiar properties of the data of the experimental-psychological tests tat (thematic apperception test) reflect personality changes generated by schizophrenia progression included the psychopathological phenomenon related to cannabis intoxication. |
2007-01-22 |
2023-08-12 |
Not clear |
| Maria C Jockers-Scherüb. [Schizophrenia and cannabis consumption: epidemiology and clinical symptoms]. Praxis der Kinderpsychologie und Kinderpsychiatrie. vol 55. issue 7. 2006-12-22. PMID:17058779. |
[schizophrenia and cannabis consumption: epidemiology and clinical symptoms]. |
2006-12-22 |
2023-08-12 |
Not clear |
| Maria C Jockers-Scherüb. [Schizophrenia and cannabis consumption: epidemiology and clinical symptoms]. Praxis der Kinderpsychologie und Kinderpsychiatrie. vol 55. issue 7. 2006-12-22. PMID:17058779. |
first-episode schizophrenic patients with long-term cannabis consumption were significantly younger at disease-onset, mostly male and suffered more often from paranoid schizophrenia (with a better prognosis) than those without cannabis consumption in our investigation. |
2006-12-22 |
2023-08-12 |
Not clear |
| Maria C Jockers-Scherüb. [Schizophrenia and cannabis consumption: epidemiology and clinical symptoms]. Praxis der Kinderpsychologie und Kinderpsychiatrie. vol 55. issue 7. 2006-12-22. PMID:17058779. |
taken together, the effect of cannabis on the brain vulnerable to schizophrenia is not yet completely understood; besides the undoubtedly deleterious effects, there may also be some neuroprotective effects. |
2006-12-22 |
2023-08-12 |
Not clear |
| Caroline Dubertret, Isabelle Bidard, Jean Adès, Philip Gorwoo. Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction. Schizophrenia research. vol 86. issue 1-3. 2006-12-20. PMID:16806837. |
lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction. |
2006-12-20 |
2023-08-12 |
human |
| Caroline Dubertret, Isabelle Bidard, Jean Adès, Philip Gorwoo. Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction. Schizophrenia research. vol 86. issue 1-3. 2006-12-20. PMID:16806837. |
recent prospective findings have shown that cannabis use by young people could be a risk factor for psychotic symptoms in adulthood, but the long-term impact of cannabis abuse on the clinical features of declared schizophrenia remains to be explored. |
2006-12-20 |
2023-08-12 |
human |
| Caroline Dubertret, Isabelle Bidard, Jean Adès, Philip Gorwoo. Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction. Schizophrenia research. vol 86. issue 1-3. 2006-12-20. PMID:16806837. |
the incidence of the abuse of drugs other than cannabis was nearly five times greater amongst patients with both schizophrenia and cannabis abuse. |
2006-12-20 |
2023-08-12 |
human |
| Caroline Dubertret, Isabelle Bidard, Jean Adès, Philip Gorwoo. Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction. Schizophrenia research. vol 86. issue 1-3. 2006-12-20. PMID:16806837. |
when the analyses were limited to subjects with no other abuse, less avolution and fewer apathy symptoms were still detected in patients with schizophrenia and cannabis abuse than in those with no abuse (p=0.0001). |
2006-12-20 |
2023-08-12 |
human |
| Caroline Dubertret, Isabelle Bidard, Jean Adès, Philip Gorwoo. Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction. Schizophrenia research. vol 86. issue 1-3. 2006-12-20. PMID:16806837. |
the strong association between cannabis abuse and fewer negative symptoms in schizophrenia was thus replicated in this sample, but once co-morbid addictive disorders had been controlled no influence of cannabis abuse on hallucinations was detected. |
2006-12-20 |
2023-08-12 |
human |
| Caroline Dubertret, Isabelle Bidard, Jean Adès, Philip Gorwoo. Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction. Schizophrenia research. vol 86. issue 1-3. 2006-12-20. PMID:16806837. |
distinguishing the effects of co-occurring addictive disorder(s) in patients with schizophrenia and cannabis dependence may thus be important when attempting to analyse the impact of cannabis abuse. |
2006-12-20 |
2023-08-12 |
human |
| Merete Nordentof. [Cannabis and psychosis]. Ugeskrift for laeger. vol 168. issue 45. 2006-11-30. PMID:17118250. |
longitudinal studies of the association between use of cannabis and later psychosis or schizophrenia were reviewed. |
2006-11-30 |
2023-08-12 |
Not clear |
| E J Barkus, J Stirling, R S Hopkins, S Lewi. Cannabis-induced psychosis-like experiences are associated with high schizotypy. Psychopathology. vol 39. issue 4. 2006-11-01. PMID:16636640. |
recent studies have suggested that cannabis use is a risk factor for developing schizophrenia. |
2006-11-01 |
2023-08-12 |
human |